Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

Item
http://www.wikidata.org/entity/Q37567461
Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis.Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis.Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil.Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.Safety and immunogenicity of a novel therapeutic DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Defining and characterizing sustained remission in patients with rheumatoid arthritis.Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis.
P2860

Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

Item
http://www.wikidata.org/entity/Q37567461
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@en
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@nl
type
label
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@en
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@nl
prefLabel
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@en
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Systematic review of tumor nec ...... udies in rheumatoid arthritis.
@en
P2093
P2860
P304
P31
P356
10.1016/J.CLINTHERA.2013.09.015
P433
P478
P50
P577
P698
P921
P932